The objective of the Riverside Healthcare Screening and Risk Assessment Program is to empower, educate and provide resources to patients who can benefit from genetic testing. The National Comprehensive Cancer Network, US Preventative Services Task Force, and American College of Obstetrics and Gynecology have specific guidelines regarding referral for genetic counseling based on family history for a number of different settings. Individuals found to have hereditary cancer or cancer predisposition are candidates for increased surveillance and prevention options. The Riverside Healthcare Screening and Risk Assessment Program will incorporate these guidelines into personalized care plans for each patient.
Julie Sieling, CNP
Riverside Healthcare Screening and Risk Assessment Program
Julie helps to guide patients every step of the way. From helping patients complete the initial risk assessment to discussing the benefits and limitations of genetic testing to interpreting results and providing recommendations, education, and follow-up, Julie’s role is to help guide patients along their Screening and Risk Assessment journey. She’s there to answer any questions that may arise and help to empower patients in making more informed healthcare choices.
Frequently Asked Questions
Who may benefit from genetic testing?
A simple, 30-second questionnaire will be offered to get the information needed to discuss cancer risk and determine if there are any red flags in the personal or family health history. Red flags include:
- Multiple cancers on the same side of the family
- Diagnosis of breast, colorectal or endometrial cancer at age 50 or younger
- A rare cancer diagnosis, such as ovarian or male breast cancer at any age
- Ashkenazi Jewish ancestry
- Three family members affected by either pancreatic, breast or ovarian cancer
What does the myRisk Hereditary Cancer Panel test include?
The myRisk Hereditary Cancer Panel consists of 25 genes that impact inherited risks for eight cancers including:
When will the myRisk Hereditary Cancer Panel test results be available?
The patient’s panel is typically available in 3 to 4 weeks, at which time the Breast Center Nurse Practitioner meets personally with each patient to counsel and discuss the findings, next steps, recommendations and management plans. A copy of the results, along with national guideline recommendations, will be shared with the patient’s provider and included in the patient’s electronic medical record to assist in further screening management for high risk patients. Patients who desire or are in need of referrals to specialists or additional resources will have the guidance and support provided by the team at Riverside to help navigate the network of comprehensive services and programs available at Riverside Healthcare and beyond.
What is the cost?
Depending on the type of testing needed, genetic testing can cost between $375 and $2,900. Medicare and most insurance companies cover the cost when specific patient criteria are met. Myriad, the myRisk Hereditary Cancer Panel genetics laboratory, will verify each patient’s insurance coverage before running the test. The test will only be completed upon authorization from the patient. Payment plans and assistance through Myriad are available when needed.
For more information about the Screening and Risk Assessment Program at Riverside Healthcare contact Julie Sieling, CNP at 779-701-2777.